A2 Milk is looking to recover from the impact of its lost market share in China after its infant milk formula supply to the region was hammered by global supply chain constraints in the wake of the US-Iran war.
The disruption left A2 unable to stock certain infant milk products during April and May, an issue which it admitted saw many customers switch to alternative brands. Before the supply chain collapse, China-labelled infant milk formula products were set to generate $535 million in annualised sales, but the collapse led to a 60 per cent sales decline by August.
A2 Milk told investors that it has already recovered these sales to 50 per cent of pre-collapse performance. It is also launching an aggressive multi-tier program to recover market share.
This program includes efforts to rebuild consumer trust through increased marketing, recruit new customers with enhanced loyalty programs, improve the distribution network and launch two new China-labelled products.
The company said it still expects revenue and earnings to grow in fiscal 2027. It did, however, warn of further headwinds.
Challenges such as economic conditions and continued supply-related risks were cited, along with ongoing uncertainty around interest rates and commodity prices.
Despite these, A2 Milk still aims to reach the $2 billion revenue mark by the end of fiscal 2027.
